{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-274634","form_type":"8-K","ticker":"CSTL","cik":"0001447362","company_name":"CASTLE BIOSCIENCES INC","filed_at":"2023-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.102551+00:00","generated_at":"2026-06-08T06:26:26.188343+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Castle Biosciences adopts Severance and Change in Control Plan for top executives","bullets":["Plan adopted Nov 3, 2023; covers CEO Maetzold, CFO Stokes, CCO Juvenal, COO Oelschlager.","On CIC termination: CEO gets 36 months salary + 300% target bonus; others get 12 months salary + prior year bonus.","On non-CIC termination: CEO gets 18 months salary + 150% target bonus; others get 12 months salary + 100% target bonus.","Equity acceleration: 100% on CIC termination; pro-rata for 12/18 months on non-CIC termination.","Plan replaces prior severance benefits under employment agreements."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-274634","json":"https://secwatch.observer/filing/0001193125-23-274634.json","markdown":"https://secwatch.observer/filing/0001193125-23-274634.md","text":"https://secwatch.observer/filing/0001193125-23-274634.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1447362/000119312523274634/0001193125-23-274634-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1447362/000119312523274634/d530518d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T06:26:26.188343+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}